期刊文献+

老年与非老年组多发性骨髓瘤的临床细胞遗传学和预后的比较 被引量:5

原文传递
导出
摘要 目的 研究老年多发性骨髓瘤(multiple myeloma,MM)的细胞遗传学、临床因素与预后的相互关系.方法 采用添加细胞因子的改良72 h培养法制备染色体标本,用R显带技术,对64例MM进行核型分析.结果 29例65岁以下MM患者中,发现有异常核型7例,发生率24.14%(7/29);伴多发性骨破坏13例,发生率44.83%(1 3/29).35例65岁以上的老年MM患者中,发现有异常核型16例,发生率45.71%(16/35);伴多发性骨破坏22例,发生率62.85%(22/35).结论 老年组与非老年组MM患者在细胞遗传学、骨破坏程度、骨髓浆细胞百分比的差异均有统计学意义.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2010年第6期710-711,共2页 Chinese Journal of Medical Genetics
  • 相关文献

参考文献7

  • 1Robert K,Morie G,Thomas W,et al.Review of 1027 patients with newly diagnosed multiple myeloma.Mayo Clin Proc,2003,78:21-23.
  • 2张之甫.血液病诊断及疗效标准.第3版.北京:北京科学技术出版杜,2007.232-235.
  • 3ISCN(2009):An International System for Human Cgtogenetic Nomenclature.Miteltnan F.S.Karger,Basel,2009.
  • 4麦玉洁,邱录贵,李睿,靳风艳,白洁,万长春,王建祥,季林祥,肖志坚,钱林生.432例多发性骨髓瘤临床分析[J].白血病.淋巴瘤,2004,13(4):198-201. 被引量:27
  • 5庄俊玲,武永吉,钟玉萍,何坚,沈悌,张之南.多发性骨髓瘤218例临床分析[J].中国实用内科杂志,2004,24(2):108-110. 被引量:61
  • 6杨艳敏,单莹.多发性骨髓瘤初诊误诊分析[J].中国误诊学杂志,2003,3(11):1662-1663. 被引量:8
  • 7Zhan F,Sawyer J,Tricot G.The role of cytogenetics in myeloma.Leukemia,2006,20:1481-1486.

二级参考文献10

  • 1李守静,李宏然,赵相印,李清朗.多发性骨髓瘤诊断的探讨(附2547例分析)[J].中华肿瘤杂志,1995,17(1):43-46. 被引量:151
  • 2武永吉 张安.骨髓瘤前期2例[J].中华内科杂志,1992,31:545-546.
  • 3Greipp R P, Leong T, Bennett J, et al. Plasmablastic morphology-an independent prognostic factor with clinical and laboratory correlates:Eastern Cooperative Oncology Group (ECOG)Myeloma Trial E9486 Report by the ECOG Myeloma Laboratory Group[J]. Blood,199
  • 4Zojer N, Konigsberg R, Ackermann J, et al. Deletinn of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detectinn by interphase fluorescence in situ hubridization[J]. Blood,2000,95(6)1925-1930.
  • 5Fonseca R, Harrington D ,Oken M, et al. Biologic al and prognostic significance of interphase fluorescence in situ hubridization detection of chromosome 13 abnormalities (△ 13)in multiple myeloma:an Eastern Cooperative Oncology Group Study[J]. Cancer Rea
  • 6Robert K, Morie G, Thomas W, et al. Review of 1027 patients with newly diagnosed multiple myeloma[J]. Mayo Clin Proc, 2003,78:21 -33.
  • 7Knudsen L M, Hjorth M, Hippe E. Renal failure in multiple myeloma: reversibility and impact on the prognosis[J]. Eur J Haematol,2000,65:175-181.
  • 8Shaheen H, Ghanghroo Ⅰ, Malik Ⅰ. Clinicopathological features and management of Pakistani patients with multiple myeloma[J]. J Pak Med Assoc, 1999, 49(10):233-237.
  • 9杨玉花,王良绪,赵昕.自体外周血造血干细胞移植治疗多发性骨髓瘤12例临床疗效观察[J].中华血液学杂志,1998,19(11):590-591. 被引量:4
  • 10武永吉,李惠鹏.125例多发性骨髓瘤临床分析[J].中华血液学杂志,1992,13(7):349-351. 被引量:42

共引文献86

同被引文献30

  • 1张艳,江滨,黄晓军,师岩,何琦,党辉,邱镜滢,陆道培.多发性骨髓瘤的细胞遗传学研究[J].中国实验血液学杂志,2007,15(1):76-78. 被引量:20
  • 2Nguyen AN, Stebbins EG, Henson M, et al. Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation. Exp Cell Res,2006,312 : 1909-1923.
  • 3Robert K, Morie G,Thomas W, et al, Review o{ 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc,2003 ,78 : 21 33 .
  • 4Heinrich PC,Behrmann I, Haan S, et al. Principles of interleukin (IL) -6-type cytokine signaling and its regulation. Biochem J, 2003, 374:1-20.
  • 5Nilsson T,Lenhoff S, Turesson I, et al. Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation. Eur J Haematol, 2002 ,68..345-353.
  • 6FaconT, Lai JL, Natal" E, et al . Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients. BrJ Haematol, 1993,84:743-745.
  • 7Debes-Marum CS, Dewald GW, Bryant S, et al. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia, 2003,17:427-436.
  • 8Mao C. Cytogenefies in leukemia and its aflas[M], l.sl ed. Beijing: Peole's Medical Press, 2015:205 206,.
  • 9Cen I: Jiang Y, Chen T, et al. Clinical analysis of chromosome ahnormalities in 100 patients with muhiple myeloma by fluorescencein shu hybridization[J].Chin J Intern Med, 2013, 52(9): 757 -778.
  • 10Zhang ZN, Shen T. The diagnosis and criterion of therapeutical effect of hematopathy[M]. 3rd ed. Beijing: Science Press, 2007: 232-235.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部